VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $817,000 | -20.2% | 51,324 | +4.2% | 0.39% | -19.3% |
| Q4 2017 | $1,024,000 | +39.5% | 49,255 | -3.8% | 0.49% | +38.1% |
| Q3 2017 | $734,000 | -23.6% | 51,188 | -7.8% | 0.35% | -25.6% |
| Q2 2017 | $961,000 | +64.8% | 55,543 | +5.0% | 0.47% | +57.1% |
| Q1 2017 | $583,000 | +23.8% | 52,896 | +63.0% | 0.30% | +11.1% |
| Q4 2016 | $471,000 | +20.2% | 32,449 | +103.4% | 0.27% | +16.8% |
| Q3 2016 | $392,000 | +94.1% | 15,954 | +58.7% | 0.23% | +90.2% |
| Q2 2016 | $202,000 | – | 10,053 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |